---
figid: PMC4339430__12943_2015_306_Fig6_HTML
figlink: /pmc/articles/PMC4339430/figure/Fig6/
number: F6
caption: Schematic diagram of the proposed role of CCL21/CCR7 axis in lymphangiogenesis.
  (A, B) Molecular crosstalk between tumor cells and LECs. 1) Tumor cells enhance
  the expression of VEGF-C in response to CCL21/CCR7 signaling and promote sprouting
  of new lymphatics. 2) CCR7-expressing LECs have a direct lymphangiogenic potential
  by stimulating the pro-lymphangiogenic traits of LECs. 3) LECs respond to CCL21/CCR7
  axis through the modulation of VEGFR-3 signaling pathway.
pmcid: PMC4339430
papertitle: The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
reftext: Elena Tutunea-Fatan, et al. Mol Cancer. 2015;14:35.
pmc_ranked_result_index: '16446'
pathway_score: 0.9392105
filename: 12943_2015_306_Fig6_HTML.jpg
figtitle: Proposed role of CCL21/CCR7 axis in lymphangiogenesis
year: '2015'
organisms:
- Mus musculus
- unidentified
- Homo sapiens
ndex: f15bc7af-dea7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4339430__12943_2015_306_Fig6_HTML.html
  '@type': Dataset
  description: Schematic diagram of the proposed role of CCL21/CCR7 axis in lymphangiogenesis.
    (A, B) Molecular crosstalk between tumor cells and LECs. 1) Tumor cells enhance
    the expression of VEGF-C in response to CCL21/CCR7 signaling and promote sprouting
    of new lymphatics. 2) CCR7-expressing LECs have a direct lymphangiogenic potential
    by stimulating the pro-lymphangiogenic traits of LECs. 3) LECs respond to CCL21/CCR7
    axis through the modulation of VEGFR-3 signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - PIK3CB
  - PIK3R6
  - FLT4
  - CCR2
  - PIK3CD
  - AKT1
  - EAF2
  - PIK3CA
  - CCL16
  - CCL21
  - PIK3R3
  - CCR7
  - PIK3R5
  - AKT3
  - VEGFC
  - PIK3CG
  - PIK3R4
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: VEGFR-3
  symbol: VEGFR3
  source: hgnc_alias_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: CCR2
  symbol: CCR2
  source: hgnc_symbol
  hgnc_symbol: CCR2
  entrez: '729230'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: traits
  symbol: TRAITS
  source: hgnc_alias_symbol
  hgnc_symbol: EAF2
  entrez: '55840'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: LEC
  symbol: LEC
  source: hgnc_alias_symbol
  hgnc_symbol: CCL16
  entrez: '6360'
- word: CCL21
  symbol: CCL21
  source: hgnc_symbol
  hgnc_symbol: CCL21
  entrez: '6366'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: CCR7
  symbol: CCR7
  source: hgnc_symbol
  hgnc_symbol: CCR7
  entrez: '1236'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: VEGF-C
  symbol: VEGFC
  source: hgnc_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals: []
diseases: []
figid_alias: PMC4339430__F6
redirect_from: /figures/PMC4339430__F6
figtype: Figure
---
